Skip to main content
Clinical Trials/NCT01927172
NCT01927172
Unknown
N/A

AirSonea Wheeze Detection Study - Multipart Clinical Performance Assessment to Determine Agreement on Wheeze Detection Between AirSonea™ Versus Physician Auscultation and an Expert Panel.

iSonea0 sites85 target enrollmentSeptember 2013
ConditionsCOPDAsthma

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD
Sponsor
iSonea
Enrollment
85
Primary Endpoint
Device Efficacy
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine if the AirSonea device provides an objective assessment of breath sounds for the presence of wheeze in both medical and home environments.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
August 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
iSonea
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Part I: Participants presenting to an Acute Care Setting with an exacerbation of asthma or chronic obstructive pulmonary disease symptoms
  • Part II: Volunteer participants without asthma
  • Part III: Participants with asthma
  • For all parts of study
  • Age: 18 years or older
  • Participant has signed an Informed Consent after having the Study explained to them.

Exclusion Criteria

  • Any medical finding by the physician that would exclude the patient from participating.
  • \< than 18 years of age

Outcomes

Primary Outcomes

Device Efficacy

Time Frame: 1 day

Device wheeze detection as compared to physician wheeze detection via auscultation.

Secondary Outcomes

  • Wheeze Rate break points(Up to 1 week)

Similar Trials